As in the overall cohort, we detected lower PEMT expression in postmenopausal women with fibrosis compared to milder NASH stages, although these analyses were limited by the number of individuals in the different NAFLD stages. The gene discussed is PEMT; the disease is metabolic dysfunction-associated steatohepatitis.